HBF-0259

Modify Date: 2024-01-14 17:26:45

HBF-0259 Structure
HBF-0259 structure
Common Name HBF-0259
CAS Number 957011-15-3 Molecular Weight 364.20
Density N/A Boiling Point N/A
Molecular Formula C16H12Cl2FN5 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of HBF-0259


HBF-0259 is a potent and selective inhibitor of hepatitis B virus (HBV) surface antigen (HBsAg) secretion, with an EC50 of 1.5 μM in HepG2.2.15 cells. HBF-0259 has no effect on HBV DNA synthesis[1][2].

 Names

Name HBF-0259

 HBF-0259 Biological Activity

Description HBF-0259 is a potent and selective inhibitor of hepatitis B virus (HBV) surface antigen (HBsAg) secretion, with an EC50 of 1.5 μM in HepG2.2.15 cells. HBF-0259 has no effect on HBV DNA synthesis[1][2].
Related Catalog
In Vitro HBF-0259 (0.0158-50.0 μM) inhibits the HBsAg secretion (EC50=1.5 μM) in HepDE19 cells, with an CC50 of >50 μM[1]. HBF-0259 (2-8 μM) significantly reduces the abundance of both L and M in the supernatants of HepG2.2.15 cells[1].
References

[1]. Dougherty AM, et, al. A substituted tetrahydro-tetrazolo-pyrimidine is a specific and novel inhibitor of hepatitis B virus surface antigen secretion. Antimicrob Agents Chemother. 2007 Dec;51(12):4427-37.

[2]. Yu W, et, al. Design, synthesis, and biological evaluation of triazolo-pyrimidine derivatives as novel inhibitors of hepatitis B virus surface antigen (HBsAg) secretion. J Med Chem. 2011 Aug 25;54(16):5660-70.

 Chemical & Physical Properties

Molecular Formula C16H12Cl2FN5
Molecular Weight 364.20